These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33073329)

  • 1. The impact of hospital-diagnosed depression or use of antidepressants on treatment initiation, adherence and HbA
    Rohde C; Knudsen JS; Schmitz N; Østergaard SD; Thomsen RW
    Diabetologia; 2021 Feb; 64(2):361-374. PubMed ID: 33073329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Within-Subject Before-After Study of the Impact of Antidepressants on Hemoglobin A1c and Low-Density Lipoprotein Levels in Type 2 Diabetes.
    Rohde C; Thomsen RW; Østergaard SD
    J Clin Psychopharmacol; 2022 Mar-Apr 01; 42(2):125-132. PubMed ID: 35001061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register.
    Karlsson SA; Franzén S; Svensson AM; Miftaraj M; Eliasson B; Andersson Sundell K
    BMC Health Serv Res; 2018 Nov; 18(1):900. PubMed ID: 30486824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycaemic, blood pressure and cholesterol control in 25 629 diabetics.
    Pinchevsky Y; Butkow N; Chirwa T; Raal FJ
    Cardiovasc J Afr; 2015; 26(4):188-92. PubMed ID: 26407221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct trajectories of HbA
    Rathmann W; Schwandt A; Hermann JM; Kuss O; Roden M; Laubner K; Best F; Ebner S; Plaumann M; Holl RW;
    Diabet Med; 2019 Nov; 36(11):1468-1477. PubMed ID: 31392761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive multifactorial treatment modifies the effect of family history of diabetes on glycaemic control in people with Type 2 diabetes: a post hoc analysis of the ADDITION-Denmark randomized controlled trial.
    Eliraqi GM; Vistisen D; Lauritzen T; Sandbaek A; Jørgensen ME; Faerch K
    Diabet Med; 2015 Aug; 32(8):1085-9. PubMed ID: 25819139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in the achievement of HbA
    Bakke Å; Dalen I; Thue G; Cooper J; Skeie S; Berg TJ; Jenum AK; Claudi T; Fjeld Løvaas K; Sandberg S
    Diabet Med; 2020 Sep; 37(9):1471-1481. PubMed ID: 31651045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder.
    Vega C; Becker RV; Mucha L; Lorenz BH; Eaddy MT; Ogbonnaya AO
    Curr Med Res Opin; 2017 Oct; 33(10):1879-1889. PubMed ID: 28644095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treat-to-target HbA
    Gagliardino JJ; Elgart J; Forti L; Guaita MS; Chantelot JM
    Diabetes Metab Res Rev; 2019 Sep; 35(6):e3166. PubMed ID: 30963685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment adjustment and medication adherence for complex patients with diabetes, heart disease, and depression: a randomized controlled trial.
    Lin EH; Von Korff M; Ciechanowski P; Peterson D; Ludman EJ; Rutter CM; Oliver M; Young BA; Gensichen J; McGregor M; McCulloch DK; Wagner EH; Katon WJ
    Ann Fam Med; 2012; 10(1):6-14. PubMed ID: 22230825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant medication use and glycaemic control in co-morbid type 2 diabetes and depression.
    Brieler JA; Lustman PJ; Scherrer JF; Salas J; Schneider FD
    Fam Pract; 2016 Feb; 33(1):30-6. PubMed ID: 26743722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact on glycated haemoglobin of a biological response-based measure of medication adherence.
    Nichols GA; Rosales AG; Kimes TM; Tunceli K; Kurtyka K; Mavros P; Steiner JF
    Diabetes Obes Metab; 2015 Sep; 17(9):843-8. PubMed ID: 25880136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethnic disparities in initiation and intensification of diabetes treatment in adults with type 2 diabetes in the UK, 1990-2017: A cohort study.
    Mathur R; Farmer RE; Eastwood SV; Chaturvedi N; Douglas I; Smeeth L
    PLoS Med; 2020 May; 17(5):e1003106. PubMed ID: 32413037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database.
    Farmer AJ; Rodgers LR; Lonergan M; Shields B; Weedon MN; Donnelly L; Holman RR; Pearson ER; Hattersley AT
    Diabetes Care; 2016 Feb; 39(2):258-263. PubMed ID: 26681714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchmarking study: baseline results from six European countries.
    Hermans MP; Brotons C; Elisaf M; Michel G; Muls E; Nobels F;
    Eur J Prev Cardiol; 2013 Dec; 20(6):1095-105. PubMed ID: 22605788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: a randomized controlled trial.
    Bogner HR; Morales KH; de Vries HF; Cappola AR
    Ann Fam Med; 2012; 10(1):15-22. PubMed ID: 22230826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of guideline-concordant depression treatment and patient adherence to oral diabetes medications.
    Nau DP; Chao J; Aikens JE
    Res Social Adm Pharm; 2005 Sep; 1(3):378-88. PubMed ID: 17138485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA
    Young TK; Li JW; Kang A; Heerspink HJL; Hockham C; Arnott C; Neuen BL; Zoungas S; Mahaffey KW; Perkovic V; de Zeeuw D; Fulcher G; Neal B; Jardine M
    Diabetologia; 2021 Nov; 64(11):2402-2414. PubMed ID: 34448033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health and economic impact of improved glucose, blood pressure and lipid control among German adults with type 2 diabetes: a modelling study.
    Fan M; Stephan AJ; Emmert-Fees K; Peters A; Laxy M
    Diabetologia; 2023 Sep; 66(9):1693-1704. PubMed ID: 37391625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring concurrent oral hypoglycemic and antidepressant adherence and clinical outcomes.
    Bogner HR; de Vries HF; O'Donnell AJ; Morales KH
    Am J Manag Care; 2013 Mar; 19(3):e85-92. PubMed ID: 23534947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.